|
Wed, 09/09/2020 - 21:54 |
Green Light Therapy Shown to Reduce Migraine Frequency, Intensity |
ArizonaUniv |
|
Wed, 09/09/2020 - 01:46 |
New School Year Can Bring Stress and Headaches for Children |
Piedmont Henry ... |
|
Tue, 08/18/2020 - 03:04 |
An amino acid alleviates hangover symptoms |
HelsinkiUniv |
|
Tue, 11/12/2019 - 07:50 |
Pfizer Announces Results of Phase 3 Study for XELJANZ (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting |
Pfizer |
|
Mon, 08/26/2019 - 11:42 |
An innovative diagnostic for Lyme disease |
Biodesign Institute |
|
Mon, 07/29/2019 - 08:00 |
Kaplan USMLE Step 1 prep: Which drug to blame for womans symptoms? |
AMA |
|
Tue, 07/09/2019 - 09:32 |
Allergan Continues to Demonstrate Leadership in Migraine with 29 Presentations at the 2019 American Headache Society Annual Meeting |
Allergan |
|
Mon, 06/03/2019 - 23:42 |
FDA approves first treatment for episodic cluster headache that reduces the frequency of attacks |
FDA |
|
Mon, 04/01/2019 - 21:43 |
How Can We Help You Today? |
Tufts Medical Center |
|
Tue, 03/12/2019 - 03:48 |
Vertex Receives Approval for SYMDEKO (tezacaftor/ivacaftor and ivacaftor) in Australia, to Treat the Underlying Cause of Cystic Fibrosis in People aged 12 and Older with Certain CFTR Gene Mutations |
Vertex |
|
Wed, 01/23/2019 - 07:56 |
Tool Offers Nonopioid Options For Acute Migraine in the ED |
ASHP |
|
Mon, 01/14/2019 - 15:47 |
Ferring Pharmaceuticals adds two products to its robust reproductive health portfolio in the U.S. |
Ferring Pharmac... |
|
Mon, 01/07/2019 - 07:04 |
AcelRx Pharmaceuticals announces publication analyzing pooled data on sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain |
AcelRx Pharmace... |
|
Mon, 12/31/2018 - 17:33 |
Tevas AJOVY Receives EU Approval Offering Patients the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Prophylaxis of Migraine in Adults |
Teva Pharmaceutical |
|
Fri, 12/21/2018 - 15:24 |
FDA approves new treatment for adult patients with rare, life-threatening blood disease |
FDA |
|
Fri, 12/21/2018 - 04:11 |
Novartis receives European Commission (EC) approval for expanded indication for Kisqali (ribociclib) |
Novartis |
|
Thu, 12/20/2018 - 14:24 |
Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer |
Pfizer |
|
Thu, 12/20/2018 - 03:42 |
LYNPARZA (olaparib) Meets Primary Endpoint in Phase 3 SOLO-3 Trial for the Treatment of Relapsed BRCA-Mutated Advanced Ovarian Cancer |
Cubist Pharmace... |
|
Wed, 12/19/2018 - 05:04 |
Flu is Serious for Pregnant Women and Others at High Risk |
Infectious Dise... |
|
Wed, 12/19/2018 - 04:35 |
LYNPARZA (olaparib) Approved by FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer |
Cubist Pharmace... |
|
Tue, 12/18/2018 - 10:38 |
Lexicon Pharmaceuticals Announces Positive Topline Clinical Data for LX9211 |
Lexicon Pharmac... |
|
Tue, 12/18/2018 - 10:14 |
Vertex Announces Positive Phase 2 Data in Third Proof-of-Concept Study with the NaV1.8 Inhibitor VX-150 |
Vertex |
|
Thu, 12/13/2018 - 10:44 |
Health Canada Grants Market Authorization for ORKAMBI (lumacaftor/ivacaftor) for Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease |
Vertex |
|
Wed, 12/12/2018 - 10:47 |
Havana Embassy Phenomenon: Researchers Report Acute Findings |
UniversityofPit... |
|
Tue, 12/11/2018 - 07:55 |
Amicus Therapeutics Awarded United Kingdom Prix Galien Medal for Galafold (Migalastat) |
amicus |
